Group 1 - The core viewpoint of the news is the performance and holdings of the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A, which has shown significant growth in recent months and year-to-date [1]. - As of June 23, 2025, the fund's latest net value is 0.6735 yuan, reflecting a growth of 2.14% [1]. - The fund's performance over the past month has yielded a return of 9.25%, ranking 105 out of 4699 in its category [1]. - Over the last six months, the fund has achieved a return of 34.70%, ranking 72 out of 4539 [1]. - Year-to-date, the fund has returned 35.79%, ranking 89 out of 4559 [1]. Group 2 - The top ten stock holdings of the fund account for a total of 56.30%, with the largest positions being: Kelun-Botai (9.63%), BeiGene-U (8.84%), and Kangfang Biotech (7.07%) [1]. - The fund was established on August 21, 2020, and as of March 31, 2025, it has a total scale of 1.68 billion yuan [1]. - The fund manager is Zheng Lei, who has extensive experience in the medical and healthcare investment sector [2].
6月23日汇添富医疗积极成长一年持有混合A净值增长2.14%，今年来累计上涨35.79%
Sou Hu Cai Jing·2025-06-23 11:55